Date Filer Title Filing Type Shares Traded Price Total Held
Apr 01, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 775,000 -- 775,000
Apr 01, 2021
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Sep 03, 2020
Chief Medical Officer
Chief Medical Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 03, 2020
Chief Financial Officer
Chief Financial Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 350,000 -- 350,000
Sep 01, 2020
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 -- 225,000
Jun 30, 2020
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.